Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bartolini

Showing results (1401-1410 of 2,014) with videos related to

Pageof 202
Sort By:
Viruses|April 3, 2021
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C LightAnna Gidari, Samuele Sabbatini, Sabrina Bastianelli, et al.
AJNR. American Journal of Neuroradiology|May 25, 2023
Early-versus-Late Endovascular Stroke Treatment: Similar Frequencies of Nonrevascularization and Postprocedural Cerebrovascular Complications in a Large Single-Center Cohort StudyE Maslias, S Nannoni, B Bartolini, et al.
Pathology, Research and Practice|April 22, 2021
IDH1<sup>105GGT</sup> single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomasEnrico Franceschi, Dario De Biase, Vincenzo Di Nunno, et al.
ACS Applied Energy Materials|May 14, 2023
Orange/Red Benzo[1,2-<i>b</i>:4,5-<i>b</i>']dithiophene 1,1,5,5-Tetraoxide-Based Emitters for Luminescent Solar Concentrators: Effect of Structures on Fluorescence Properties and Device PerformancesMatteo Bartolini, Cosimo Micheletti, Alberto Picchi, et al.
Tumori|May 18, 2021
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective studyEnrico Franceschi, Santino Minichillo, Alicia Tosoni, et al.
European Journal of Clinical Pharmacology|February 1, 2018
NSAIDs utilization for musculoskeletal indications in elderly patients with cerebro/cardiovascular diseaseGiuseppe Roberto, Claudia Bartolini, Federico Rea, et al.
Science (New York, N.Y.)|May 11, 2019
Temporal patterning of apical progenitors and their daughter neurons in the developing neocortexL Telley, G Agirman, J Prados, et al.
Scientific Data|May 18, 2023
M100 ExaData: a data collection campaign on the CINECA's Marconi100 Tier-0 supercomputerAndrea Borghesi, Carmine Di Santi, Martin Molan, et al.
Neuroscience|April 2, 2020
Growth Hormone Receptor Deletion Reduces the Density of Axonal Projections from Hypothalamic Arcuate Nucleus NeuronsFrederick Wasinski, Isadora C Furigo, Pryscila D S Teixeira, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2006
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapyF Cappuzzo, S Novello, F De Marinis, et al.
Pageof 202

Showing results (1401-1410 of 2,014) with videos related to

Sort By:
Pageof 202
Viruses|April 3, 2021
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C LightAnna Gidari, Samuele Sabbatini, Sabrina Bastianelli, et al.
AJNR. American Journal of Neuroradiology|May 25, 2023
Early-versus-Late Endovascular Stroke Treatment: Similar Frequencies of Nonrevascularization and Postprocedural Cerebrovascular Complications in a Large Single-Center Cohort StudyE Maslias, S Nannoni, B Bartolini, et al.
Pathology, Research and Practice|April 22, 2021
IDH1<sup>105GGT</sup> single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomasEnrico Franceschi, Dario De Biase, Vincenzo Di Nunno, et al.
ACS Applied Energy Materials|May 14, 2023
Orange/Red Benzo[1,2-<i>b</i>:4,5-<i>b</i>']dithiophene 1,1,5,5-Tetraoxide-Based Emitters for Luminescent Solar Concentrators: Effect of Structures on Fluorescence Properties and Device PerformancesMatteo Bartolini, Cosimo Micheletti, Alberto Picchi, et al.
Tumori|May 18, 2021
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective studyEnrico Franceschi, Santino Minichillo, Alicia Tosoni, et al.
European Journal of Clinical Pharmacology|February 1, 2018
NSAIDs utilization for musculoskeletal indications in elderly patients with cerebro/cardiovascular diseaseGiuseppe Roberto, Claudia Bartolini, Federico Rea, et al.
Science (New York, N.Y.)|May 11, 2019
Temporal patterning of apical progenitors and their daughter neurons in the developing neocortexL Telley, G Agirman, J Prados, et al.
Scientific Data|May 18, 2023
M100 ExaData: a data collection campaign on the CINECA's Marconi100 Tier-0 supercomputerAndrea Borghesi, Carmine Di Santi, Martin Molan, et al.
Neuroscience|April 2, 2020
Growth Hormone Receptor Deletion Reduces the Density of Axonal Projections from Hypothalamic Arcuate Nucleus NeuronsFrederick Wasinski, Isadora C Furigo, Pryscila D S Teixeira, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2006
A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapyF Cappuzzo, S Novello, F De Marinis, et al.
Pageof 202